Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2581-2588

  Peterlik, Meinrad ^a   Cross, Heide S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmune diseases; CYP27B1; Extra renal vitamin D metabolism; Hypovitaminosis D; Osteoporosis; Review; Vitamin D insufficiency

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; CALCIUM; COLECALCIFEROL; STEROID; VITAMIN D;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; BLADDER CANCER; BREAST CANCER; CANCER RISK; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CHRONIC DISEASE; COLORECTAL CANCER; CROHN DISEASE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG POTENTIATION; ENDOCRINE SYSTEM; ENTERITIS; ENZYME ACTIVITY; EPITHELIUM CELL; ESOPHAGUS CANCER; HUMAN; IMMUNOCOMPETENT CELL; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MELANOMA; MESENCHYME CELL; MULTIPLE SCLEROSIS; NONHUMAN; OSTEOPOROSIS; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; STOMACH CANCER; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; UTERUS CANCER; VITAMIN D DEFICIENCY;

ANIMALS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 1; ENDOCRINE SYSTEM; HUMANS; INFLAMMATORY BOWEL DISEASES; MULTIPLE SCLEROSIS; OSTEOPOROSIS; VITAMIN D DEFICIENCY;

EID: 33746612936     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. 3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 60: 960-966, 1985.
2. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PAH and Chakraverty R: Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170: 5382-5390, 2003.
3. 3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol 62: 21-28, 1997.
4. Bareis P, Bises G, Bischof MG, Cross HS and Peterlik M: 25-hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285: 1012-1017, 2001.
5. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E and Peterlik M: 25-Hydroxyvitamin D-3-1 alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66: 287-292, 2001.
6. 3 into their respective lactones. Endocrinology 136: 4195-4203, 1995.
7. 2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis. Life Sci 61: 977-985, 1997.
8. Pillai S, Bikle DD and Elias PM: 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 263: 5390-5395, 1988.
9. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM and Hewison M: Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
10. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, Stewart PM and Hewison M: Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 13: 621-629, 2002.
11. Zittermann A: Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89: 552-572, 2003.
12. Peterlik M and Cross HS: Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35: 290-304, 2005.
13. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69: 842-856, 1999.
14. 3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 89-90: 575-579, 2004.
15. Whiting SJ and Calvo MS: Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J Nutr 135: 304-309, 2005.
16. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S and Meunier PJ: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7: 439-443, 1997.
17. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD and Bouter LM: Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10: 1177-1184, 1995.
18. Lamberg-Allardt CJ, Outila TA, Karkkainen MU, Rita HJ and Valsta LM: Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 16: 2066-2073, 2001.
19. Scharla SH: Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int 8 Suppl 2: S7-12, 1998.
20. Dawson-Hughes B, Harris SS and Dallal GE: Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 65: 67-71, 1997.
21. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K, Woloszczuk W and Willvonseder R: Normative data of bone mineral density in an unselected adult Austrian population. Eur J Clin Invest 33: 332-339, 2003.
22. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K, Woloszczuk W and Willvonseder R: Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 33: 323-331, 2003.
23. Broadus A. E. Mineral Balance and Homeostasis. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Favus MJ (ed.). Washington, DC: American Society for Bone and Mineral Research, pp. 105-111, 2003.
24. Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, Laureys J, Rutgeerts O, Saint-Arnaud R, Bouillon R and Mathieu C: Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120: 139-146, 2000.
25. Vieth R: The pharmacology of vitamin D, including fortification strategies. In: Vitamin D. Feldman D, Pike WJ, Glorieux FH (eds.). Amsterdam: Elsevier, pp. 995-1015, 2005.
26. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M and Hakama M: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108: 104-108, 2004.
27. Garland CF and Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-231, 1980.
28. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW and Bowman BA: Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76: 187-192, 2002.
29. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK and Gorham ED: Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2: 1176-1178, 1989.
30. Holt PR, Arber N, Halmos B, Forde K, Kissileff H, McGlynn KA, Moss SF, Kurihara N, Fan K, Yang K and Lipkin M: Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 11: 113-119, 2002.
31. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW and Giovannucci EL: Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13: 1502-1508, 2004.
32. Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J and Albanes D: Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8: 615-625, 1997.
33. Grant WB and Garland CF: A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 48: 115-123, 2004.
34. Grant WB: An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875, 2002.
35. Grant WB: Ecologic studies of solar UV-B radiation and cancer mortality rates. Rec Results Cancer Res 164: 371-377, 2003.
36. Bareis P, Bises G, Bischof MG, Cross HS and Peterlik M: 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285: 1012-1017, 2001.
37. Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S and Cross HS: Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22: 1429-1435, 2001.
38. Cross HS, Pavelka M, Slavik J and Peterlik M: Growth control of human colon cancer cells by vitamin D and calcium in vitro. J Natl Cancer Inst 84: 1355-1357, 1992.
39. Cross HS, Hulla W, Tong WM and Peterlik M: Growth regulation of human colon adenocarcinoma-derived cells by calcium, vitamin D and epidermal growth factor. J Nutr 125(7 Suppl): 2004S-2008S, 1995.
40. Hulla W, Kallay E, Krugluger W, Peterlik M and Cross HS: Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression. Int J Cancer 62: 711-716, 1995.
41. Tong WM, Hofer H, Ellinger A, Peterlik M and Cross HS: Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. Oncol Res 11: 77-84, 1999.
42. 3-1alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004.
43. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W and Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Rec Results Cancer Res 164: 239-246, 2003.
44. 3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7: 391-395, 1998.
45. 3. Carcinogenesis 25: 1015-1026, 2004.
46. Grant WB: An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94: 272-281, 2002.
47. Freedman DM, Dosemeci M and McGlynn K: Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 59: 257-262, 2002.
48. Anonymous: Osteoporosis prevention, diagnosis, and therapy. JAMA 285: 785-795, 2001.
49. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS and Lian JB: Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128: 1496-1504, 1991.
50. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327: 1637-1642, 1992.
51. Grant WB: Solar UV-B radiation is linked to the geographic variation of mortality from systemic lupus erythematosus in the USA. Lupus 13: 281-282, 2004.
52. Sonnenberg A, McCarty DJ and Jacobsen SJ: Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 100: 143-149, 1991.
53. Podolsky DK: Inflammatory bowel disease. N Engl J Med 325: 928-1016, 1991.
54. Hypponen E, Laara E, Reunanen A, Jarvelin MR and Virtanen SM: Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358: 1500-1503, 2001.
55. Merlino L, Curtis J, Mikuls TR, Cerhan JR, Criswell LA and Saag KG: Vitamin D intake is inversely associated with rheumatoid arthritis. Results from the Iowa Women's Health Study. Arthr Rheumat 50: 72-77, 2004.
56. Ponsonby AL, McMichael A and van der Mei I: Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181-182: 71-78, 2002.
57. Embry A: Vitamin D supplementation in the fight against multiple sclerosis. J Orthomol Med 19: 27-38, 2004.
58. Embry A: The multiple factors of multiple sclerosis. J Nutr Environm Med 14: 1-11, 2004.
59. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE and Cantorna MT: A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17: 2386-2392, 2003.
60. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93: 7861-7864, 1996.
61. Cantorna MT, Hayes CE and DeLuca HF: 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128: 68-72, 1998.
62. Cantorna MT, Munsick C, Bemiss C and Mahon BD: 1,25- Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130: 2648-2652, 2000.
63. 3. J Neuroimmunol 61(2): 151-160, 1995.
64. Hayes CE, Nashold FE, Spach KM and Pedersen LB: The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 49: 277-300, 2003.
65. 3 on mouse peritoneal macrophage functions. J Immunol 143: 3686-3690, 1989.
66. 3 with IL-12 and IL-4 on cytokine expression of human T lymphocytes. J Allergy Clin Immunol 116: 683-689, 2005.
67. 3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 84: 3739-3744, 1999.
68. Targan SR and Murphy LK: Clarifying the causes of Crohn's. Nat Med 1: 1241-1243, 1995.
69. Farrell RJ and Peppercorn MA: Ulcerative colitis. Lancet 359: 331-340, 2002.
70. Itzkowitz S: Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol 36 (5 Suppl): S70-74 2003.
71. Goldberg P: Multiple sclerosis; vitamin D and calcium as environmental determinants of prevalence. Part 1: Sunlight, dietary factors and epidemiology. Int J Environ Studies 6: 19-27, 1974.
72. Goldberg P: Multiple sclerosis; vitamin D and calcium as environmental determinants of prevalence. Part 2: Biochemical and genetic factors. Int J Environ Studies 6: 121-129, 1974.
73. Cantorna MT, Humpal-Winter J and DeLuca HF: Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129: 1966-1971, 1999.
74. Giulietti A, Gysemans C, Stoffels K, Van Etten E, Decallonne B, Overbergh L, Bouillon R and Mathieu C: Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 47: 451-462, 2004.
75. 3. Diabetologia 37: 552-558, 1994.
76. 3. Curr Opin Nephrol Hypertens 4: 313-318, 1995.
77. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J and Hebert SC: Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993.
78. Chattopadhyay N and Brown EM: Calcium-sensing Receptor. Boston: Kluwer Academic Publishers, 2003.
79. Larsen ER, Mosekilde L and Foldspang A: Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 19: 370-378, 2004.
80. Grau MV, Baron JA, Sandier RS, Haile RW, Beach ML, Church TR and Heber D: Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95: 1765-1771, 2003.
81. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA and Willett WC: Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94: 1301-1311, 2002.
82. Mathieu C, Van Etten E, Gysemans C, Decallonne B, Kato S, Laureys J, Depovere J, Valckx D, Verstuyf A and Bouillon R: In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res 16: 2057-2065, 2001.